脂肪因子与类风湿关节炎患者新发骨质疏松性骨折的关联
三种脂肪因子均升高者骨折风险为均不升高者的2.17倍。
要点
- 高瘦素水平与骨折风险升高相关(HR=1.47,95%CI 1.15-1.90,P=0.003)
- 高FGF-21水平与骨折风险升高相关(HR=1.39,95%CI 1.16-1.67,P<0.001)
- 三种脂肪因子均升高者骨折风险为均不升高者的2.17倍(95%CI 1.27-3.70,P=0.005)
核心结论
- 脂肪因子升高与类风湿关节炎患者骨折风险增加相关,独立于体重指数、吸烟和泼尼松使用等既定危险因素。
- 作者认为这支持进一步研究该关联是否与体成分改变或代谢通路紊乱有关。
研究设计与样本
- 纵向类风湿关节炎队列研究,使用入组时储存的血清检测三种脂肪因子(脂联素、瘦素、成纤维细胞生长因子21),按中位数二分高/低水平。
- 新发骨质疏松性骨折基于已发表算法用诊断代码定义,并经病历回顾确认;采用Cox比例风险模型评估脂肪因子与新发骨折风险的关联。
主要发现
- 高瘦素水平者新发骨折风险升高(HR=1.47,95%CI 1.15-1.90,P=0.003)。
- 高FGF-21水平者新发骨折风险升高(HR=1.39,95%CI 1.16-1.67,P<0.001)。
- 高脂联素水平者新发骨折风险未达统计学显著(HR=1.21,95%CI 0.94-1.55,P=0.13)。
- 三种脂肪因子均升高者骨折风险为均不升高者的2.17倍(95%CI 1.27-3.70,P=0.005)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为这支持进一步研究以理解该关联是否与体成分改变或代谢通路紊乱有关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed whether circulating adipokines are associated with incident fractures in patients with rheumatoid arthritis (RA). METHODS: Three adipokines (adiponectin, leptin, and fibroblast growth factor [FGF]-21) were measured using banked enrollment serum from participants in a longitudinal RA cohort. Adipokine levels were dichotomized as high/low using median values. Incident osteoporotic fracture was defined based on published algorithms using diagnostic codes and confirmed by chart review. Cox proportional hazard models evaluated adipokines and incident fracture risk adjusting for age, sex, race, smoking status, body mass index (BMI), prednisone use, disease activity, comorbidity score, calendar year, osteoporosis history, and previous fracture. RESULTS: A total of 2,527 participants were included (89% male, mean age 72 years). There were 228 incident fractures over 27,540 person-years of follow-up (8.3 fractures per 1,000 person-years). After adjustment, the risk of incident fracture was increased for high levels of leptin (hazard ratio [HR] = 1.47; 95% confidence interval [CI] 1.15-1.90; P = 0.003), FGF-21 [HR = 1.39; 95% CI 1.16-1.67; P < 0.001), and adiponectin (HR = 1.21; 95% CI 0.94-1.55), with the latter not achieving significance (P = 0.13). Participants who had elevated levels of all three adipokines experienced twice the risk of fracture compared with those in whom none was elevated (HR = 2.17; 95% CI 1.27-3.70; P = 0.005). CONCLUSION: Elevations in adipokines are associated with an increased risk of fracture in patients with RA, independent of other established risk factors including BMI, smoking, and prednisone use. This supports further investigation to understand whether this association is related to altered body composition or disrupted metabolic pathways.
引用
- Baker JF, England BR, George MD, et al. Adipokines and Associations With Incident Osteoporotic Fracture in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2025. PMID: 40827014. doi:10.1002/acr.25632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。